Botulinum toxin injections for spasticity

Operative Techniques in Neurosurgery

Volumn 7, Issue 3 SPEC. ISS., 2004, Pages 128-135

  Anwar, Khalid ^a   Barnes, Michael P ^a,b  

^a Hunters Moor Regional Rehabilitation Centre   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Botulinum toxin injections; Increased muscle tone; Spasticity

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BOTULINUM TOXIN A; BOTULINUM TOXIN B; NEUTRALIZING ANTIBODY;

ANAPHYLAXIS; BLEPHAROSPASM; BRAIN INJURY; BRUXISM; CEREBRAL PALSY; CLOSTRIDIUM BOTULINUM; CONSTIPATION; DEGENERATIVE DISEASE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; DYSPHAGIA; DYSTONIA; ELECTROMYOGRAM; ESOPHAGUS ACHALASIA; FATIGUE; FLU LIKE SYNDROME; FOOD AND DRUG ADMINISTRATION; HEMIFACIAL SPASM; HUMAN; HYPERHIDROSIS; IMMUNITY; INJECTION PAIN; MIGRAINE; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; MYOCLONUS; MYOKYMIA; NEUROMUSCULAR TRANSMISSION; OBESITY; OCCUPATIONAL THERAPY; PHYSIOTHERAPY; PRIORITY JOURNAL; PTOSIS; REVIEW; SPASTICITY; SPINAL CORD INJURY; STRABISMUS; STROKE; SWEAT GLAND DISEASE; TENSION HEADACHE; VAGINISM; XEROSTOMIA;

EID: 19444376916     PISSN: 1092440X     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.otns.2005.01.002     Document Type: Article

References (80)

1. J.W. Lance Symposium synopsis R.G. Feldman R.R. Young W.P. Koella Spasticity Disordered Motor Control 1980 Year Book Medical Publishers Chicago 485 494
2. R.R. Young Treatment of spastic paresis N Engl J Med 320 1989 1553 1555
3. R.R. Young Spasticity A review Neurology 44 1994 512 520
4. M.F. Brin M. Hallet J. Jankovic Scientific and therapeutic aspects of botulinum toxin 2002 Lippincott Williams and Wilkins Philadelphia 1 507
5. H. Bigalke, D. Dressler, J. Jankovic Basic and therapeutic aspects of neurotoxins Mov Disord 19 suppl 8 2004 S1 S4
6. J. Jankovic, M.F. Brin Botulinum toxin, historical perspective and potential new indications Muscle Nerve (suppl 6) 20 1997 S129 S145
7. J. Jankovic, K. Schwartz Response and immunoresistance to botulinum toxin injections Neurology 45 1995 1743 1746
8. Spasticity Study Group M.F. Brin Dosing, administration and a treatment algorithm for use of botulinum toxin A for adult onset spasticity Muscle Nerve 20 suppl 6 1997 S209
9. F.J. Erbguth, M. Naumannn Historical aspects of botulinum toxin Justin Kerner (1786-1862) and the "sausage" poison. Neurology 53 1999 1850 1853
10. P.P. Devriese On the discovery of Clostridum botulinum J History Neurosci 8 1999 43 50
11. S.S. Arnon, R. Schecter, T.V. Inglesby Botulinum toxin as a biological weapon. Medical and public health management JAMA 285 2001 1059 1070
12. A.B. Scott Botulinum toxin injection of eye muscles to correct strabismus Trans Am Ophthalmol Soc 79 1981 734 739
13. T.K. Das, D.M. Park Effect of treatment with botulinum toxin on spasticity Postgrad Med J 65 1989 208 210
14. R. Tintner, J. Jankovic Focal dystonia The role of botulinum toxin Curr Neurol Neurosci 1 2001 337 454
15. J. Jankovic Botulinum toxin in clinical practice J Neurol Neurosurg Psychiatry 75 2004 951 957
16. J.M. Gracies, H. Hefter, D.M. Simpson Spasticity in adults M. Naumann P. Moore Handbook of Botulinum Toxin Treatment 2003 Blackwell Science Ltd Oxford 219 269
17. M. Barnes, D. Best, L. Kidd The use of botulinum toxin type B in the treatment of the patients who have become unresponsive to botulinum toxin type A, initial experiences Eur J Neurol 2005 (in press)
18. B.J. Snow, J.K. Tsui, D.B. Calne Treatment of spasticity with botulinum toxin A double-blind study Ann Neurol 28 1990 512 515
19. R. Dengler, U. Neyer, K. Wolfarth Local botulinum toxin in the treatment of spastic foot drop J Neurol 239 1992 375 378
20. A. Chutorian, L. Root Management of spasticity in children with botulinum A toxin Intl Paediatrics 9 1994 35 43
21. A. Chutorian, L. Root BTA Study Group A multi centered, randomised, double-blind placebo-controlled trial of botulinum toxin type A in the treatment of lower limb spasticity in paediatric cerebral palsy Mov Disord 10 1995 364 (Abstr)
22. L. Koman, J.F. Mooney III, B.P. Smith Botulinum toxin Potential role in management of cerebral palsy during childhood Jankovic M. Hallet Therapy with Botulinum Toxin 1994 Marcel Dekker New York 511 522
23. D.D. Dykstra, A.A. Sidi Treatment of detrusor sphincter dyssynergia with botulinum A toxin A double-blind study Arch Phys Med Rehabil 71 1990 24 26
24. I.S. Corry, A.P. Cosgrove, E.G. Walsh Botulinum toxin A in the hemiplegic upper limb A double-blind trial Dev Med Child Neurol 39 1997 185 193
25. M.A. Grazko, K.B. Polo, G. Ford Effectiveness of botulinum toxin A in patients with spasticity Mov Disord 45 1995 712 717
26. B. Memin, P. Pollack, M. Hommel Effects of botulinum toxin on spasticity Rev Neurol (Paris) 148 1992 212 214
27. D.M. Simpson, D.N. Alexander, C.F. O'Brien Botulinum toxin type A in the treatment of upper extremity spasticity A randomised, double-blind placebo-controlled trial Neurology 46 1996 1306 1310
28. G.L. Sheean Botulinum treatment of spasticity Why is it so difficult to show a functional benefit? Curr Opin Neurol 14 2001 771 776
29. S.J. Smith, E. Ellis, S. White A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury Clin Rehabil 14 2000 5 13
30. r) with placebo in upper limb spasticity after stroke Stroke 31 2000 2402 2406
31. D. Richardson, G.L. Sheean, D. Werring Evaluating the role of botulinum toxin in the management of focal hypertonia in adults J Neurol Neurosurg Psychiatry 69 2000 499 506
32. B.B. Bhakta, J.A. Cozens, M.A. Chamberlain Impact of botulinum toxin type A on disability and care burden due to arm spasticity after stroke A randomised double blind placebo controlled trial J Neurol Neurosurg Psychiatry 69 2000 217 221
33. A.M. Bakheit, S. Pittock, A.P. Moore A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke Eur J Neurol 8 2001 559 565
34. D.T. Wade, R. Langton-Hewer, V.A. Wood The hemiplegic patient. A measurement and recovery J Neurol Neurosurg Psychiatry 46 1983 521 524
35. A.S.V. Burgen, F. Dickens, L.J. Zatman The action of botulinum toxin on the neuromuscular junction J Physiol 109 1949 10 24
36. D.A. Tonge Chronic effects of botulinum toxin on neuromuscular transmission and sensitivity to acetylcholine in slow and fast skeletal muscles of the mouse J Physiol 241 1974 127 139
37. L.C. Sellin, S. Thesleff, B.R. Dasgupta Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction Acta Physiol Scand 119 1983 127 133
38. M. Hallet, F.X. Glocker, G. Deuschl Mechanism of action in botulinum toxin Ann Neurol 36 1994 449 450
39. J.A. Coffield, N. Bakry, L.L. Simpson In vitro characterization of botulinum toxin types A, C and D action on human tissues Combined electrophysiologic, pharmacologic and molecular biologic approaches J Pharmacol Exp Ther 280 1997 1489 1498
40. J. Sanchez-Prieto, T.S. Sihra, D. Evans Botulinum toxin A blocks glutamate exocytosis from guinea-pig cerebral cortical synaptosomes Eur J Biochem 165 1987 675 681
41. J.A. Kauffman, J.F. Way Jr, L.S. Siegel Comparison of the actions of types A and F botulinum toxin at the rat neuromuscular junction Toxicol Appl Pharmacol 79 1958 21 217
42. R. Eleopra, V. Tugnoli, R. Quatrale Different types of botulinum toxin in humans Mov Disord 19 suppl 8 2004 S53 S59
43. D.D. Whelchel, T.M. Brehmer, P.M. Brooks Molecular targets of botulinum toxin at the mammalian neuromuscular junction Mov Disord 19 suppl 8 2004 S7 S16
44. M.Z. Atassi Basic immunological aspects of botulinum toxin therapy Mov Disord 19 suppl 8 2004 S68 S84
45. B.R. DasGupta Structures of botulinum neurotoxin, its functional domains, and perspectives on the crystalline type A toxin J. Jankovic M. Hallet Therapy with botulinum toxin 1994 Marcel Dekker New York 15 39
46. G. Schiavo, O. Rossetto, B.R. DasGupta Botulinum neurotoxins are zinc proteins J Biol Chem 267 1992 23479 23787
47. M.A. Hanson, R.C. Stevens Structural view of botulinum neurotoxin in numerous functional states M.F. Brin M. Hallet J. Jankovic Scientific and Therapeutic Aspects of Botulinum Toxin 2002 Lippincott Williams & Wilkins Philadelphia
48. J. Blasé, E. Chapman, E. Link Botulinum neurotoxin selectively cleaves the synapse protein SNAP-25 Nature 265 1993 160 163
49. A. De Paiva, F.A. Meunier, J. Molgo Functional repair of motor end plates after botulinum neurotoxin A poisoning Bi-phasic switch of synaptic activity between nerve sprouts and their parent terminals Proc Natl Acad Sci USA 96 1999 3200 3205
50. M.F. Brin, A. Blitzer Botulinum toxin Dangerous errors J R Soc Med 86 1993 493 494 (letter)
51. T. Odergren, H. Hjaltson, S. Kaakkola Double blind, randomised, parallel group study to investigate the dose equivalence of dysport and botox in the treatment of cervical dystonia J Neurol Neurosurg Psychiatry 64 1998 6 12
52. C. Sampaio, J.J. Ferreira, F. Simoes DYSBOT A single blind, randomised parallel study to determine whether any differences can be detected in the efficacy and tolerability of the formulations of botulinum toxin type A dysport and botox assuming a ratio of 4:1 Mov Disord 12 1997 1013 1018
53. National Institutes of Health Consensus Development Conference Clinical use of botulinum toxin Arch Neurol 48 1991 1294 1298
54. R. Eleopra, V. Tugnoli, L. Caniatti Botulinum toxin treatment in the facial muscles of humans Evidence of an action in untreated near muscles by peripheral local diffusion Neurology 46 1996 1158 1160
55. G.E. Borodic, R. Ferrante, L.B. Pearce Histologic assessment of dose-related diffusion and muscle fibre response after therapeutic botulinum toxin A injections Mov Disord 9 1994 31 39
56. R. Stell, P.D. Thompson, C.D. Marsden Botulinum toxin in spasmodic torticollis J Neurol Neurosurg Psychiatry 51 1988 920 923
57. J.D. Blackie, A.J. Lees Botulinum toxin treatment in spasmodic torticollis J Neurol Neurosurg Psychiatry 53 1990 640 643
58. J.J. Dutton Acute and chronic effects of botulinum toxin in the management of blepharospasm J. Jankovic M. Hallet Therapy with Botulinum Toxin 1994 Marcel Dekker New York 199 209
59. S. Jitpimolmard, S. Tiamkao, N. Laopaiboon Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm a report of 175 cases J Neurol Neurosurg Psychiatry 64 1998 751 757
60. A.M.O. Bakheit, C.D. Ward, D.L. McLellan Generalized botulism like syndrome after intramuscular injections of botulinum toxin type A A report of two cases J Neurol Neurosurg Psychiatry 62 1997 198
61. K.P. Bhattia, A. Munchau, P.D. Thompson Generalized muscular weakness after botulinum toxin injections for dystonia A report of three cases J Neurol Neurosurg Psychiatry 67 1999 90 93
62. R.K. Olney, M.J. Aminoff, D.J. Gelb Neuromuscular effects distant from the site of botulinum neurotoxin injections Neurology 38 1988 1780 1783
63. W.T. Dauer, R.E. Burke, P. Greene Current concepts on the clinical findings and associated movement disorders Neurology 41 1991 1088 1091
64. W. Poewe, J. Wissel Experience with botulinum toxin in cervical dystonia J. Jankovic M. Hallet Therapy with Botulinum Toxin 1994 Marcel Dekker New York 211 237
65. P. Hambleton, H.E. Cohen, B.J. Palmer Antitoxins and botulinum toxin treatment BMJ 304 1992 959 960
66. G.E. Borodic, E. Johnson, M. Goodnough Botulinum toxin therapy, immunological resistance, and problems with available materials Neurology 46 1996 26 29 (review)
67. P. Green, S. Fahn, Diamond Development of resistance to botulinum toxin type A in patients with torticollis Mov Disord 9 1994 213 217
68. P.A. Hanna, J. Jankovic Mouse bioassay versus western blot assay for botulinum toxin antibodies. Correlation with clinical response Neurology 50 1998 1624 1629
69. G. Palace, A. Nairne, N. Hyman A radio-immuno-precipitation assay for antibodies to botulinum toxin a Neurology 50 1998 1463 1466
70. J. Jankovic, K. Schwartz Response and immunoresistance to botulinum toxin injections Neurology 45 1995 1743 1746
71. M.F. Brin, M.F. Lew, M.D. Adler Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A resistant cervical dystonia Neurology 53 1999 1431 1438
72. The Wemove Spasticity Study Group Dosing, administration and a treatment algorithm for use of botulinum toxin type A for adult onset muscle overactivity N. Mayer D. Sunpson Spasticity Etiology, Evaluation, Management and the Role of Botulinum Toxin 2002 We Move New York 154 166
73. M.F. Brin Spasticity Study Group Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity Muscle Nerve 20 suppl 6 1997 S208 S220
74. S.H. Pierson Outcome measures in spasticity management Muscle Nerve 20 suppl 6 1997 S36 S60
75. N.H. Mayer, A. Esquenazi, M.K. Childers Common patterns of clinical motor dysfunction Muscle Nerve 20 suppl 6 1997 S21 S35
76. C.F. O'Brien Injection techniques for botulinum toxin using electromyography and electrical stimulation Muscle Nerve 20 suppl 6 1997 S176 S180
77. B.S. Russman, A. Tilton, M.E. Gormley Jr Cerebral palsy A rational approach to treatment protocol, and the role of botulinum toxin in treatment Muscle Nerve 20 suppl 6 1997 S181 S193
78. C.M. Shaari, I. Sanders Quantifying how location and dose of botulinum toxin injections affect muscle paralysis Muscle Nerve 16 1993 964 969
79. H. Bigalke, K. Wohlfarth, A. Irmer Botulinum a toxin (Dysport). Improvement of biological availability Exp Neurol 168 2001 162 170
80. K. Albany Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity Muscle Nerve 20 suppl 6 1997 S221 S231